Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04110522 · ClinicalTrials.gov registry record · NA
Psoriatic Arthritis D2P Screening
A NA study of Psoriatic Arthritis, sponsored by Jessica Walsh.
- Recruiting
- Registry status
- NA
- Development phase
- 18,000
- Enrollment target
- 2
- Study locations
NCT04110522 is a NA study of Psoriatic Arthritis that is actively recruiting participants, run by Jessica Walsh. The registered enrollment target is 18,000 participants, above the 478-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (3666% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT04110522, a NA study of Psoriatic Arthritis, is actively recruiting participants, sponsored by Jessica Walsh.
- RECRUITING
- Registry status
- NA
- Development phase
- 18,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overarching goal of this study is to develop a direct-to-patient screening approach that will improve early Psoriatic Arthritis (PsA) detection in patients with psoriasis. Previously developed screening questionnaires were intended for use in the setting of a doctor's office to assist providers with referral decisions. However, these screening questionnaires are infrequently used in routine practice because of limitations with time and resources. The study will aim to develop a practical screening strategy that does not require involvement from dermatologists (or other non-rheumatology providers) and can systematically reach a broad range of psoriasis patients, including patients not attending dermatology clinics. The researchers hypothesize that disseminating questionnaires directly to patients outside of a clinic setting (direct-to-patient approach) will educate patients about their PsA risk and improve early PsA diagnoses.
Conditions Studied
Interventions
- OTHER Direct to patient PsA Screening Questionnaire
Study Locations (2)
Pennsylvania
- University of Pennsylvania - Philadelphia
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,000 participants |
| Start Date | 2019-07-22 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04110522
The ClinicalTrials.gov registry entry for NCT04110522 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 18,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 478-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (3666% higher). The listed sponsor is Jessica Walsh, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Psoriatic Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Direct to patient PsA Screening Questionnaire is the first listed.
NCT04110522 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Utah.
Frequently Asked Questions
What is clinical trial NCT04110522 about?
NCT04110522 is a clinical study titled "Psoriatic Arthritis D2P Screening". The overarching goal of this study is to develop a direct-to-patient screening approach that will improve early Psoriatic Arthritis (PsA) detection in patients with psoriasis. Previously developed screening questionnaires were intended for use in the setting of a doctor's office to assist providers ...
What is the current status of trial NCT04110522?
This trial is currently recruiting. It is a NA study. The enrollment target is 18,000 participants. The study started on 2019-07-22. Estimated completion is 2025-12-31.
What conditions does trial NCT04110522 study?
This clinical trial studies the following conditions: Psoriatic Arthritis.
What interventions are being tested in trial NCT04110522?
The interventions under investigation include: Direct to patient PsA Screening Questionnaire (OTHER).
Who is sponsoring clinical trial NCT04110522?
This trial is sponsored by Jessica Walsh, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04110522 being conducted?
This trial has 2 study locations across Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriatic Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
RECRUITING · NA
-
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
ACTIVE NOT RECRUITING · NA
-
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
ACTIVE NOT RECRUITING · NA
-
Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.